Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | SLC16A6 |
| Upstream (Parents) |
|---|
| (<<) ACAT2 → SLC16A6 |
| (<<) BRCA1 → SLC16A6 |
| (<<) CASP10 → SLC16A6 |
| (<<) CCND1 → SLC16A6 |
| (<<) CXCL3 → SLC16A6 |
| (<<) EEF1E1 → SLC16A6 |
| (<<) FUT1 → SLC16A6 |
| (<<) GNA15 → SLC16A6 |
| (<<) ICAM2 → SLC16A6 |
| (<<) IER3 → SLC16A6 |
| (<<) INVS → SLC16A6 |
| (<<) LTA4H → SLC16A6 |
| (<<) NFIB → SLC16A6 |
| (<<) PIK3R1 → SLC16A6 |
| (<<) PLA2G12A → SLC16A6 |
| (<<) RPS6KB1 → SLC16A6 |
| (<<) TMEM154 → SLC16A6 |
| (<<) UBE2E3 → SLC16A6 |
| Downstream (Children) |
|---|
| SLC16A6 → EPHA4 (>>) |
| SLC16A6 → FCRLB (>>) |
| SLC16A6 → NEUROG3 (>>) |
| SLC16A6 → NFIA (>>) |
